EUVIMEDEUVIMED entdecken
Crossref

Risk factors for postgastric endoscopic submucosal dissection bleeding in direct oral anticoagulant users

Tomo Kagawa, Shigenao Ishikawa, Yu Hidaka, Hugh Shunsuke Colvin, Akira Nakanishi, Jumpei Ohkawa, Shin Negishi, Eriko Yasutomi, Kenji Yamauchi, Kunio Okamoto, Ichiro Sakakihara, Koichi Izumikawa und 7 weitere

Digestive Endoscopy · 2024

DOI: 10.1111/den.14806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Endoscopy, 2024. Verfasst von Tomo Kagawa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Kagawa Prefectural Central Hospital, Kagawa, Japan. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Postoperative Hemorrhage, Stomach Neoplasms, Anticoagulants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Bleeding after endoscopic submucosal dissection (ESD) for gastric tumors in patients taking antithrombotic drugs, in particular direct oral anticoagulants (DOACs), remains unresolved; therefore, we evaluated the risk factors for post‐ESD bleeding and drug differences in patients taking DOACs.

Methods

We included 278 patients taking antithrombotic drugs who underwent gastric ESD between January 2017 and March 2022. Antithrombotic drugs were withdrawn following the 2017 guidelines (Appendix on anticoagulants including DOACs). To further clarify differences in antithrombotic agents' effects, the peri‐cancerous mucosa in the resected specimen was pathologically evaluated according to the Updated Sydney System. Multivariate analysis was performed to assess the risk of post‐ESD bleeding.

Results

The incidence of post‐ESD bleeding in patients taking DOACs was 19.6% (10/51). Among patients taking antithrombotic drugs, DOACs were identified as a possible factor involved in post‐ESD bleeding (odds ratio [OR] 4.92). Among patients taking DOACs, possible factors included resection length diameter ≥30 mm (OR 3.72), presence of neutrophil infiltration (OR 2.71), lesions occurring in the lower third of stomach (OR 2.34), and preoperative antiplatelet use (OR 2.22). Post‐ESD bleeding by DOAC type was 25.0% of patients (4/16) receiving apixaban, in 20.0% (3/15) receiving edoxaban, in 21.4% (3/14) receiving rivaroxaban, and in none of those receiving dabigatran.

Conclusions

The administration of DOACs was shown to be a possible factor involved in post‐ESD bleeding, and risk factors for patients taking DOACs included neutrophil infiltration. The pharmacological differences in the effects of DOACs contributing to bleeding in gastric ulcers suggest comparatively less bleeding with dabigatran after ESD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionPostoperative HemorrhageStomach NeoplasmsAnticoagulantsHumansMaleFemaleAgedRisk FactorsMiddle AgedRetrospective StudiesAdministration, OralAged, 80 and overRivaroxabanDabigatranIncidencePyridonesFactor Xa InhibitorsPyrazolesPyridinesThiazoles

Stichwörter der Autor:innen

artificial ulcerdelayed bleedingdirect oral anticoagulantendoscopic submucosal dissectiongastric tumor

Substanzen

AnticoagulantsRivaroxabanDabigatranapixabanedoxabanPyridonesFactor Xa InhibitorsPyrazolesPyridinesThiazoles

Autor:innen und Institutionen

  • Department of Gastroenterology, Kagawa Prefectural Central Hospital, Kagawa, Japan.
  • Department of Medical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Medical Oncology, Kagawa Prefectural Central Hospital, Kagawa, Japan.

Zitieren

APA

Kagawa, T., Ishikawa, S., Hidaka, Y., Colvin, H. S., Nakanishi, A., Ohkawa, J., Negishi, S., Yasutomi, E., Yamauchi, K., Okamoto, K., Sakakihara, I., Izumikawa, K., Yamamoto, K., Takahashi, S., Tanaka, S., Matsuura, M., Wato, M., Hasui, T., & Inaba, T. (2024). Risk factors for postgastric endoscopic submucosal dissection bleeding in direct oral anticoagulant users. Digestive Endoscopy. https://doi.org/10.1111/den.14806

Vancouver

Kagawa T, Ishikawa S, Hidaka Y, Colvin HS, Nakanishi A, Ohkawa J, et al. Risk factors for postgastric endoscopic submucosal dissection bleeding in direct oral anticoagulant users. Digestive Endoscopy. 2024. doi:10.1111/den.14806

BibTeX
@article{Kagawa2024,
  author = {Kagawa, Tomo and Ishikawa, Shigenao and Hidaka, Yu and Colvin, Hugh Shunsuke and Nakanishi, Akira and Ohkawa, Jumpei and Negishi, Shin and Yasutomi, Eriko and Yamauchi, Kenji and Okamoto, Kunio and Sakakihara, Ichiro and Izumikawa, Koichi and Yamamoto, Kumiko and Takahashi, Sakuma and Tanaka, Shigetomi and Matsuura, Mihoko and Wato, Masaki and Hasui, Toshimi and Inaba, Tomoki},
  title = {Risk factors for postgastric endoscopic submucosal dissection bleeding in direct oral anticoagulant users},
  journal = {Digestive Endoscopy},
  year = {2024},
  doi = {10.1111/den.14806}
}
Kostenlos starten →